Arun Krishna

Arun Krishna is a seasoned pharmaceutical executive with a wealth of experience in various aspects of the industry, including Research and Development, Market Access, and Commercial operations.

He holds a Doctor of Philosophy (PhD) in Mathematics and Bio-Statistics from North Carolina State University, indicating a strong academic background in relevant fields.

Throughout his career, Arun has held key roles in prestigious organizations, showcasing his leadership and functional expertise. At AstraZeneca, he served as the Country Head of Oncology for the UK and held the position of Head of Franchise for Oncology, overseeing areas such as Immunology/Oncology and EGFR.

Prior to his time at AstraZeneca, Arun contributed significantly to Novartis, where he held the roles of UK Business Unit Director for Respiratory and Head of Commercial Operations, Executive Director and Head of Market Access in Oncology for the UK, and Director of Global Market Access & Pricing.

Arun's extensive career also includes positions at other highly regarded pharmaceutical companies such as Merck, where he served as the Director of Global Market Access and Outcomes Research, and various roles at Novartis focusing on Oncology global clinical development.

His early professional experience as an Application Developer at SAS provides a unique perspective that complements his later strategic and leadership positions in the pharmaceutical sector.